Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers

Eiichi Watanabe, Haruhiko Abe, Shigeyuki Watanabe

研究成果: Review article

6 引用 (Scopus)

抄録

Implantable cardioverter-defibrillators (ICDs) improve the survival in patients at risk of sudden cardiac death. However, these patients have an ongoing risk of sudden incapacitation that may cause harm to individuals and others when driving. Considerable disagreement exists about whether and when these patients should be allowed to resume driving after ICD therapies. This information is critical for the management decisions to avoid future potentially lethal incidents and unnecessary restrictions for ICD patients. The cardiac implantable device committee of the Japanese Heart Rhythm Society reassessed the risk of driving for ICD patients based on the literature and domestic data. We reviewed the driving restrictions of ICD patients in various regions and here present updated Japanese driving restrictions.

元の言語English
ページ(範囲)594-601
ページ数8
ジャーナルjournal of arrhythmia
33
発行部数6
DOI
出版物ステータスPublished - 12-2017

Fingerprint

Implantable Defibrillators
Sudden Cardiac Death
Equipment and Supplies
Survival

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

これを引用

Watanabe, Eiichi ; Abe, Haruhiko ; Watanabe, Shigeyuki. / Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers. :: journal of arrhythmia. 2017 ; 巻 33, 番号 6. pp. 594-601.
@article{5fc01145979149be84ac7a0f6ee5f670,
title = "Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers",
abstract = "Implantable cardioverter-defibrillators (ICDs) improve the survival in patients at risk of sudden cardiac death. However, these patients have an ongoing risk of sudden incapacitation that may cause harm to individuals and others when driving. Considerable disagreement exists about whether and when these patients should be allowed to resume driving after ICD therapies. This information is critical for the management decisions to avoid future potentially lethal incidents and unnecessary restrictions for ICD patients. The cardiac implantable device committee of the Japanese Heart Rhythm Society reassessed the risk of driving for ICD patients based on the literature and domestic data. We reviewed the driving restrictions of ICD patients in various regions and here present updated Japanese driving restrictions.",
author = "Eiichi Watanabe and Haruhiko Abe and Shigeyuki Watanabe",
year = "2017",
month = "12",
doi = "10.1016/j.joa.2017.02.003",
language = "English",
volume = "33",
pages = "594--601",
journal = "Journal of Arrhythmia",
issn = "1880-4276",
publisher = "Elsevier BV",
number = "6",

}

Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers. / Watanabe, Eiichi; Abe, Haruhiko; Watanabe, Shigeyuki.

:: journal of arrhythmia, 巻 33, 番号 6, 12.2017, p. 594-601.

研究成果: Review article

TY - JOUR

T1 - Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers

AU - Watanabe, Eiichi

AU - Abe, Haruhiko

AU - Watanabe, Shigeyuki

PY - 2017/12

Y1 - 2017/12

N2 - Implantable cardioverter-defibrillators (ICDs) improve the survival in patients at risk of sudden cardiac death. However, these patients have an ongoing risk of sudden incapacitation that may cause harm to individuals and others when driving. Considerable disagreement exists about whether and when these patients should be allowed to resume driving after ICD therapies. This information is critical for the management decisions to avoid future potentially lethal incidents and unnecessary restrictions for ICD patients. The cardiac implantable device committee of the Japanese Heart Rhythm Society reassessed the risk of driving for ICD patients based on the literature and domestic data. We reviewed the driving restrictions of ICD patients in various regions and here present updated Japanese driving restrictions.

AB - Implantable cardioverter-defibrillators (ICDs) improve the survival in patients at risk of sudden cardiac death. However, these patients have an ongoing risk of sudden incapacitation that may cause harm to individuals and others when driving. Considerable disagreement exists about whether and when these patients should be allowed to resume driving after ICD therapies. This information is critical for the management decisions to avoid future potentially lethal incidents and unnecessary restrictions for ICD patients. The cardiac implantable device committee of the Japanese Heart Rhythm Society reassessed the risk of driving for ICD patients based on the literature and domestic data. We reviewed the driving restrictions of ICD patients in various regions and here present updated Japanese driving restrictions.

UR - http://www.scopus.com/inward/record.url?scp=85016725255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016725255&partnerID=8YFLogxK

U2 - 10.1016/j.joa.2017.02.003

DO - 10.1016/j.joa.2017.02.003

M3 - Review article

AN - SCOPUS:85016725255

VL - 33

SP - 594

EP - 601

JO - Journal of Arrhythmia

JF - Journal of Arrhythmia

SN - 1880-4276

IS - 6

ER -